Novartis Investigative Site

Gdañsk 80-219

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Renal Cell Carcinoma

Studies at this site

• RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib — Completed